Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PGN 650 I-124

Next Previous
Drug Profile

PGN 650 I-124

Alternative Names: 124I-PGN 650; PGN 650; PGN-650-124-I; PGN-650-I124

Latest Information Update: 28 Jul 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Affitech A/S; University of Texas M. D. Anderson Cancer Center; University of Texas Southwestern Medical Center
  • Developer Avid Bioservices
  • Class Diagnostic agents; Imaging agents; Monoclonal antibody diagnostics
  • Mechanism of Action Radionuclide imaging enhancers; Tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for phase-0 development in Solid-tumours(Diagnosis) in USA (IV, Injection)
  • 05 Jan 2018 Peregrine Pharmaceuticals is now called Avid Bioservices
  • 09 Sep 2013 PGN 650 I-124 is still in phase 0 trials for Solid tumours (Diagnostic imaging) in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top